THE ROLE OF SOLUBLE FMS-LIKE TYROSINE KINASE-1 AND PLACENTAL GROWTH FACTOR RATIO IN THE DIAGNOSIS OF PREECLAMPSIA
Keywords:
preeclampsia, pregnancy, genetics, placental growth factor, soluble fms-like tyrosine kinase-1, hypertension.Abstract
Preeclampsia is one of the most severe complications in obstetrics, determining high rates of maternal morbidity and mortality. It continues to be a dangerous condition for the fetus, leading to delayed intrauterine development, premature births, low birth weight and perinatal mortality. There are many hypotheses of this complication in pregnancy, of which the most relevant is the theory that preeclampsia is a multifactorial disease in the development of which many genetic and environmental factors are involved.
References
Преэклампсия. Руководство. Библиотека врача-специалиста. Под ред. Сухих Г.Т., Мурашко Л.Е. М.: ГЭОТАР-Медиа. 2010;576.
Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010; 28: 1349–1355.
Foidart YM, Schaaps YP, Chantraine F. et al. Dysregylation of anti-angiogenic agents (sFlt-1, PlGF and sendoglin) in preeclampsia — a step forward but not the definitive answer. J Reprod Immunol. 2009;82:106-111.
Hammerova L, Chabada J, Drobny J, Batorova A. Lonfi tudinal evaluation of markers of hemostasis in pregnancy. Bratisl Lek Listy 2014; 115 (3): 140–144.
McElrath T, Lim K-H, Pare E, Rich-Edwards J. et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obst Ginecol. 2010; 11;407:e1-e7.
Verlohren S, Herraiz Y, Lapaire O. et al. The sFlt-1/PlGF radio in different types of hypertensive pregnancy disorders and its prognostic potential in peeclamptic patients. Am J of Obstet Gynecol. 2012;1:58:e1-e8.
Lam C, Lim K-H, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension Res. 2005;46:1077-1085.
Maynard S, Min J, Merchan J, Lim K. Excess placental soluble fms-like tyrosinekinase-1 (sFlt-1) may contribute to endometrial disfunction, hypertension and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
Roberts JM, Bell MJ. If we know so much about preeclampsia, why haven´t we cured the desease? J Reprod Immunol 2013; 99: 1–9.
Shibata E, Rajakumar A, Roberts RW. et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005;90:4895-4903.
Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors inits pathogenesis. Physiology. 2009;24:147-158.
Yelliffe-Pawlowsky L, Shaw G, Currier R. et al. Association of early preterm birth with abnormal levels of rutinely collected ferstand second-thrimester biomarkers. Am J Obstet and Gynecol. 2013;208:128-140.
